241 related articles for article (PubMed ID: 33969)
1. Ethopropazine and benztropine in neuroleptic-induced parkinsonism.
Chouinard G; Annable L; Ross-Chouinard A; Kropsky ML
J Clin Psychiatry; 1979 Mar; 40(3):147-52. PubMed ID: 33969
[TBL] [Abstract][Full Text] [Related]
2. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
Silver H; Geraisy N; Schwartz M
J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
[TBL] [Abstract][Full Text] [Related]
3. Replacement of chronically administered anticholinergic drugs by amantadine in outpatient management of chronic schizophrenia.
McEvoy JP; McCue M; Freter S
Clin Ther; 1987; 9(4):429-33. PubMed ID: 2886223
[TBL] [Abstract][Full Text] [Related]
4. Factors related to tardive dyskinesia.
Chouinard G; Annable L; Ross-Chouinard A; Nestoros JN
Am J Psychiatry; 1979 Jan; 136(1):79-82. PubMed ID: 31802
[TBL] [Abstract][Full Text] [Related]
5. High vs standard dosage fluphenazine HCL in acute schizophrenia.
Donlon PT; Meadow A; Tupin JP; Wahba M
J Clin Psychiatry; 1978 Nov; 39(11):800-4. PubMed ID: 363702
[TBL] [Abstract][Full Text] [Related]
6. Amantadine in drug-induced extrapyramidal signs: a comparative study.
Ananth J; Sangani H; Noonan JP
Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):323-6. PubMed ID: 239908
[TBL] [Abstract][Full Text] [Related]
7. Use of bethanechol chloride with phenothiazines: a case report.
Schubert DS
Am J Psychiatry; 1979 Jan; 136(1):110-1. PubMed ID: 758813
[No Abstract] [Full Text] [Related]
8. Coexisting tardive dyskinesia and parkinsonism: a case report.
De Fraites EG; Davis KL; Berger PA
Biol Psychiatry; 1977 Apr; 12(2):267-72. PubMed ID: 857938
[TBL] [Abstract][Full Text] [Related]
9. [Antiparkinson drugs in neuroleptic treatment: comparative study of progressive and abrupt withdrawal].
Ben Hadj Ali B; Dogui M; Ben Ammou S; Lôo H
Encephale; 1995; 21(3):209-15. PubMed ID: 7649071
[TBL] [Abstract][Full Text] [Related]
10. Noncompliance with antiparkinsonian medications in neuroleptic-treated schizophrenic patients: three cases of an unreported phenomenon.
Bermanzohn PC; Siris SG
J Clin Psychiatry; 1994 Nov; 55(11):488-91. PubMed ID: 7989282
[TBL] [Abstract][Full Text] [Related]
11. Comparative side effects of imipramine, benztropine, or their combination in patients receiving fluphenazine decanoate.
Siris SG; Rifkin A; Reardon GT; November M
Am J Psychiatry; 1983 Aug; 140(8):1069-71. PubMed ID: 6346910
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of L-dopa and procyclidine on neuroleptic-induced extrapyramidal and schizophrenic symptoms.
Chouinard G; Annable L; Mercier P; Turnier L
Psychopharmacol Bull; 1987; 23(1):221-6. PubMed ID: 2885889
[No Abstract] [Full Text] [Related]
13. Tardive dyskinesia and antiparkinsonian medication.
Chouinard G; De Montigny C; Annable L
Am J Psychiatry; 1979 Feb; 136(2):228-9. PubMed ID: 32778
[No Abstract] [Full Text] [Related]
14. Side effects during long-term treatment with depot antipsychotic medication.
Cookson JC
Clin Neuropharmacol; 1991; 14 Suppl 2():S24-30; discussion S30-2. PubMed ID: 1751940
[TBL] [Abstract][Full Text] [Related]
15. Inefficacy of propranolol in attenuation of drug-induced parkinsonian tremor.
Metzer WS; Paige SR; Newton JE
Mov Disord; 1993; 8(1):43-6. PubMed ID: 8093548
[TBL] [Abstract][Full Text] [Related]
16. Effects of lergotrile on schizophrenia & drug induced parkinsonism.
Small JG; Kellams JJ; Milstein V; Klapper M; Lemberger L
Commun Psychopharmacol; 1977; 1(5):461-7. PubMed ID: 23919
[No Abstract] [Full Text] [Related]
17. The initiation of long-term pharmacotherapy in schizophrenia: dosage and side effect comparisons between oral and depot fluphenazine.
Schooler NR; Levine J
Pharmakopsychiatr Neuropsychopharmakol; 1976 Jul; 9(4):159-69. PubMed ID: 790413
[TBL] [Abstract][Full Text] [Related]
18. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
Chouinard G; Annable L; Campbell W
J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
[TBL] [Abstract][Full Text] [Related]
19. The diagnosis of rapid abnormal involuntary movements associated with fluphenazine decanoate.
Glazer WM; Moore DC
J Nerv Ment Dis; 1980 Jul; 168(7):439-41. PubMed ID: 7400795
[TBL] [Abstract][Full Text] [Related]
20. Effects of anticholinergic agents on patients with tardive dyskinesia and concomitant drug-induced parkinsonism.
Wirshing WC; Freidenberg DL; Cummings JL; Bartzokis G
J Clin Psychopharmacol; 1989 Dec; 9(6):407-11. PubMed ID: 2574192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
